The neuromuscular junction disorders

被引:18
作者
Hill, M [1 ]
机构
[1] Frenchay Hosp, Inst Clin Neurosci, Bristol BS16 1LE, Avon, England
关键词
D O I
10.1136/jnnp.74.suppl_2.ii32
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuromuscular junction (NMJ) disorders result from destruction, malfunction or absence of one or more key proteins involved in neuromuscular transmission, illustrated diagrammatically in fig 1. The most common pathology is antibody mediated damage or down regulation of ion channels or receptors, resulting in myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and acquired neuromyotonia (Isaac's syndrome). Not surprisingly these three conditions share many common features (table 1). A second important group of disorders are the congenital myasthenic syndromes caused by mutations in NMJ proteins. Detailed discussion of these rare conditions is beyond the scope of this short review but interested readers are referred to a recent review by Engel and Ohno.(1).
引用
收藏
页码:II32 / II37
页数:6
相关论文
共 10 条
[1]   NEUROLOGICAL PARANEOPLASTIC SYNDROMES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - A PROSPECTIVE SURVEY OF 150 PATIENTS [J].
ELRINGTON, GM ;
MURRAY, NMF ;
SPIRO, SG ;
NEWSOMDAVIS, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (09) :764-767
[2]  
Engel Andrew G, 2002, Adv Neurol, V88, P203
[3]   Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis [J].
Gajdos, P ;
Chevret, S ;
Clair, B ;
Tranchant, C ;
Chastang, C .
ANNALS OF NEUROLOGY, 1997, 41 (06) :789-796
[4]   Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology [J].
Gronseth, GS ;
Barohn, RJ .
NEUROLOGY, 2000, 55 (01) :7-15
[5]  
Hart IK, 2001, CHANNELOPATHIES OF THE NERVOUS SYSTEM, P214
[6]   Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies [J].
Hoch, W ;
McConville, J ;
Helms, S ;
Newsom-Davis, J ;
Melms, A ;
Vincent, A .
NATURE MEDICINE, 2001, 7 (03) :365-368
[7]  
Newsom-Davis J, 1998, ANN NY ACAD SCI, V841, P817
[8]   A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis [J].
Palace, J ;
Newsom-Davis, J ;
Lecky, B .
NEUROLOGY, 1998, 50 (06) :1778-1783
[9]   Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England [J].
Robertson, NP ;
Deans, J ;
Compston, DAS .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (04) :492-496
[10]   A CLINICAL THERAPEUTIC TRIAL OF CYCLOSPORINE IN MYASTHENIA-GRAVIS [J].
TINDALL, RSA ;
PHILLIPS, JT ;
ROLLINS, JA ;
WELLS, L ;
HALL, K .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 681 :539-551